283 related articles for article (PubMed ID: 35616754)
1. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
Zhu T; Pan Z; Zhang N
Clin Rheumatol; 2022 Sep; 41(9):2791-2802. PubMed ID: 35616754
[TBL] [Abstract][Full Text] [Related]
2. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
3. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
[TBL] [Abstract][Full Text] [Related]
4. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
[TBL] [Abstract][Full Text] [Related]
5. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
6. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
7. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
[TBL] [Abstract][Full Text] [Related]
8. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
Loureiro-Amigo J; Franco-Jarava C; Perurena-Prieto J; Palacio C; Martínez-Valle F; Soláns-Laqué R
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
[TBL] [Abstract][Full Text] [Related]
10. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
[TBL] [Abstract][Full Text] [Related]
11. Alterations of CD8
Li H; Zhou Y; Wang P; Wang Y; Feng Y; Zhang Y; Wu Z
Clin Rheumatol; 2023 May; 42(5):1327-1338. PubMed ID: 36609932
[TBL] [Abstract][Full Text] [Related]
12. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome.
Lee KE; Kang JH; Yim YR; Kim JE; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Yoon KC; Lee JS; Lee SS
Clin Exp Rheumatol; 2017; 35(2):234-240. PubMed ID: 27782867
[TBL] [Abstract][Full Text] [Related]
13. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the expression levels of serum transforming growth factor-β and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
He J; Xu C; Zhu Y; Xu M; Chen Y; Guo L; Jing Z; Xu B; Wu S
Clin Rheumatol; 2023 Dec; 42(12):3283-3288. PubMed ID: 37755549
[TBL] [Abstract][Full Text] [Related]
15. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study.
Carubbi F; Alunno A; Cipriani P; Di Benedetto P; Ruscitti P; Berardicurti O; Bartoloni E; Bistoni O; Caterbi S; Ciccia F; Triolo G; Gerli R; Giacomelli R
Semin Arthritis Rheum; 2014 Dec; 44(3):314-24. PubMed ID: 24935529
[TBL] [Abstract][Full Text] [Related]
16. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
[TBL] [Abstract][Full Text] [Related]
17. Association of salivary inflammatory biomarkers with primary Sjögren's syndrome.
Moreno-Quispe LA; Serrano J; Virto L; Sanz M; Ramírez L; Fernández-Castro M; Hernández G; López-Pintor RM
J Oral Pathol Med; 2020 Oct; 49(9):940-947. PubMed ID: 32538490
[TBL] [Abstract][Full Text] [Related]
18. In patients with primary Sjögren's syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells.
Hinrichs AC; Kruize AA; Leavis HL; van Roon JAG
Front Immunol; 2022; 13():1017157. PubMed ID: 36505431
[TBL] [Abstract][Full Text] [Related]
19. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
[TBL] [Abstract][Full Text] [Related]
20. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
Front Immunol; 2021; 12():681941. PubMed ID: 34295332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
